ControversiesChallengesConsensus
}

CX 2020 LIVE pioneers virtual vascular conference format in COVID-19 era

2020-06-02T09:11:44+01:00

Chair Roger Greenhalgh (top left), moderator Andrew Holden (top right), Sapan Desai (bottom left), Sabine Steiner (bottom middle), and Misti Malone (bottom right)

CX 2020 LIVE came to life online—despite COVID-19—using state-of-the art broadcast technology to bring together more than 1,000 vascular specialists, […]

CX 2020 LIVE pioneers virtual vascular conference format in COVID-19 era2020-06-02T09:11:44+01:00

Paclitaxel controversy to headline inaugural CX 2020 LIVE session

2020-07-09T23:32:08+01:00


Join a wealth of experts and faculty from around the world for the very first session of CX 2020 LIVE—the inaugural virtual Charing Cross (CX) Symposium—titled ‘Paclitaxel-coated Device Consensus Update’.

Renowned interventional radiologist Andrew Holden (Auckland, New Zealand), who is a member of the CX Peripheral Arterial Executive Board, welcomes the […]

Paclitaxel controversy to headline inaugural CX 2020 LIVE session2020-07-09T23:32:08+01:00

Highlights from the CX 2019 session, Paclitaxel: The last word

2019-09-06T16:04:24+01:00

The 2019 Charing Cross Symposium (CX; 15–18 April, London, UK) featured an in-depth highlight session on the paclitaxel controversy. […]

Highlights from the CX 2019 session, Paclitaxel: The last word2019-09-06T16:04:24+01:00

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone

2019-09-06T16:10:43+01:00

Matteo Tozzi (Varese, Italy) discusses new data from the APERTO AVF study, the first randomised trial in China to compare the safety and efficacy of the APERTO drug-coated balloon (DCB; Cardionovum) with a high-pressure balloon. The trial results for the treatment of failing haemodialysis arteriovenous shunts were presented by Qizhuang […]

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone2019-09-06T16:10:43+01:00

Hear the latest thoughts on paclitaxel from global experts: their current practice and patient conversations

2019-09-06T16:19:25+01:00

Following the latest information presented at the Charing Cross International Symposium related to the meta-analysis of paclitaxel-coated devices (Katsanos et al, JAHA), hear from a multi-specialty panel of global experts who are discussing their current practice and the way they […]

Hear the latest thoughts on paclitaxel from global experts: their current practice and patient conversations2019-09-06T16:19:25+01:00

CX 2019: The last word on the paclitaxel controversy

2019-02-07T17:15:34+00:00

Since the publication of Katsanos et al’s meta-analysis in the Journal of the American Heart Association (JAHA), the science and support for paclitaxel-releasing devices in the legs is an unfolding story.

A CX 2019 Highlight session will feature two hours of independent review of the data and in-depth debate and discussion.

CX […]

CX 2019: The last word on the paclitaxel controversy2019-02-07T17:15:34+00:00
Go to Top